The ROE as of September 2024 (TTM) for Chugai Pharmaceutical Co., Ltd. (CHGCY) is 21.67%

According to Chugai Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 21.67%. This represents a change of 301.60% compared to the average of 5.40% of the last 4 quarters.

Chugai Pharmaceutical Co., Ltd. (CHGCY) Historical ROE (quarterly & annually)

How has CHGCY ROE performed in the past?

The mean historical ROE of Chugai Pharmaceutical Co., Ltd. over the last ten years is 16.15%. The current 21.67% ROE has changed 34.13% with respect to the historical average. Over the past ten years (40 quarters), CHGCY's ROE was at its highest in in the March 2022 quarter at 10.62%. The ROE was at its lowest in in the December 2016 quarter at 1.63%.

Chugai Pharmaceutical Co., Ltd. (CHGCY) ROE by Quarter and Year

Discovering the peaks and valleys of Chugai Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chugai Pharmaceutical Co., Ltd. (CHGCY) Average ROE

How has CHGCY ROE performed in the past?

The current ROE of Chugai Pharmaceutical Co., Ltd. (CHGCY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Chugai Pharmaceutical Co., Ltd. (CHGCY) ROE vs. Peers

How is CHGCY’s ROE compared to its peers?

Chugai Pharmaceutical Co., Ltd.’s ROE is less than Scilex Holding Company (64.26%), less than Merck & Co., Inc. (33.75%), less than Johnson & Johnson (54.01%), greater than Pfizer Inc. (-2.84%), less than Astellas Pharma Inc. (1.08%), greater than Bristol-Myers Squibb Company PFD CONV 2 (-28.46%), less than Otsuka Holdings Co., Ltd. (5.07%), less than Novartis AG (0%), less than AstraZeneca PLC (38.92%), less than GSK plc (16.80%), less than Roche Holding AG (29.50%), less than Bristol-Myers Squibb Company (54.68%), greater than Horizon Therapeutics Public Limited Company (-28.46%), less than Gilead Sciences, Inc. (5.86%), less than Sanofi (5.21%), less than null (10.71%),

Build a custom stock screener for Chugai Pharmaceutical Co., Ltd. (CHGCY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chugai Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chugai Pharmaceutical Co., Ltd. (CHGCY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chugai Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.